These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14615730)

  • 1. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group.
    Kühne T; Buchanan GR; Zimmerman S; Michaels LA; Kohan R; Berchtold W; Imbach P; ;
    J Pediatr; 2003 Nov; 143(5):605-8. PubMed ID: 14615730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?
    Treutiger I; Rajantie J; Zeller B; Henter JI; Elinder G; Rosthøj S;
    Arch Dis Child; 2007 Aug; 92(8):704-7. PubMed ID: 17460024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.
    Watts RG
    Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.
    Bennett CM; Neunert C; Grace RF; Buchanan G; Imbach P; Vesely SK; Kuhne T
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28792679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura.
    Demircioğlu F; Saygi M; Yilmaz S; Oren H; Irken G
    Pediatr Hematol Oncol; 2009; 26(7):526-32. PubMed ID: 19863209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I; Henter JI; Elinder G
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major hemorrhage in children with idiopathic thrombocytopenic purpura: immediate response to therapy and long-term outcome.
    Medeiros D; Buchanan GR
    J Pediatr; 1998 Sep; 133(3):334-9. PubMed ID: 9738712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.
    Marks MK; Vadamalayan B; Ekert H; South MJ
    J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura.
    Sandoval C; Visintainer P; Ozkaynak MF; Tugal O; Jayabose S
    Pediatr Blood Cancer; 2004 Jan; 42(1):109-12. PubMed ID: 14752803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic thrombocytopenic purpura in childhood: a population-based study in Qatar.
    Al-Mulla N; Bener A; Amer A; Abu Laban M
    J Pediatr (Rio J); 2009; 85(3):269-72. PubMed ID: 19434345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of chronic idiopathic thrombocytopenic purpura.
    ElAlfy M; Farid S; Abdel Maksoud A
    Pediatr Blood Cancer; 2010 Jul; 54(7):959-62. PubMed ID: 20405514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
    Chotsampancharoen T; Sripornsawan P; Duangchoo S; Wongchanchailert M; McNeil E
    Pediatr Blood Cancer; 2017 Jan; 64(1):128-134. PubMed ID: 27571705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study.
    Kühne T; Imbach P; Bolton-Maggs PH; Berchtold W; Blanchette V; Buchanan GR;
    Lancet; 2001 Dec 22-29; 358(9299):2122-5. PubMed ID: 11784627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.
    Vesely S; Buchanan GR; Cohen A; Raskob G; George J
    J Pediatr Hematol Oncol; 2000; 22(1):55-61. PubMed ID: 10695823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of refractory immune thrombocytopenic purpura in children: a retrospective study in a single institution.
    Ito M; Yagasaki H; Kanezawa K; Shimozawa K; Hirai M; Morioka I
    Sci Rep; 2021 Jul; 11(1):14263. PubMed ID: 34253777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.